SHL – UBS rates the stock as Neutral

By Broker News | More Articles by Broker News

Sonic reiterated FY19 guidance at its AGM, albeit with a slight tick-up on an A$ adjustment, expecting a typical second-half earnings skew. Guidance nonetheless depends on no further regulatory changes outside those already known for the US and Germany.

The broker considers geographic diversity a key positive for the stock, but has made slight valuation model adjustments which see its target fall to $23.50 from $23.90. Neutral retained.

Sector: Health Care Equipment & Services.

Target price is $23.50.Current Price is $22.45. Difference: $1.05 – (brackets indicate current price is over target). If SHL meets the UBS target it will return approximately 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).

Broker News

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →